ANTHONY R CHASE
CIK 1223756 · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.86M
Companies
10
Total Filings
137
Lifetime Open-Market Net
-$653.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NBR | Director | 15,408 | $88.89 | $1.37M | $0 | 12 | 2026-06-03 |
| CFR | Director | 1 | $167.59 | $168 | $109 | 8 | 2026-05-27 |
| LYB | Director | 13,603 | $63.07 | $857.9K | $255 | 23 | 2026-05-26 |
| PARR | Director | 10,529 | $74.56 | $785.0K | $0 | 13 | 2024-10-08 |
| Heritage-Crystal Clean, Inc. (HCCI) Delisted | Director | 1,641 | $45.51 | $74.7K | $0 | 1 | 2021-05-05 |
| APC | Director | 0 | $18.41 | $0 | $288.5K | 13 | 2019-08-09 |
| PARAGON OFFSHORE PLC (PGN) Delisted | Director | 19,616 | — | — | $0 | 5 | 2015-05-05 |
| SRPT | Director | 67,194 | $18.02 | $1.21M | -$389.7K | 11 | 2015-03-03 |
| WES | Director | 13,120 | $48.60 | $637.7K | -$880.6K | 19 | 2013-12-04 |
| Sarepta Therapeutics, Inc. (AVII) Delisted | Director | 69,411 | — | — | $328.1K | 8 | 2011-09-14 |
Recent Filings · Page 10 of 14
137 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-11-15 | SRPT | Sell (S) | −10,000 | -$257.0K | EDGAR |
| 2012-11-14 | WES | Sell (S) | −15,000 | -$729.8K | EDGAR |
| 2012-09-11 | SRPT | Sell (S) | −33,000 | -$477.0K | EDGAR |
| 2012-08-27 | SRPT | Grant (A) | +833 | $0 | EDGAR |
| 2012-05-25 | WES | Exer (M) | +1,993 | $87.6K | EDGAR |
| 2012-05-18 | WES | Grant (A) | — | $0 | EDGAR |
| 2012-04-12 | WES | Sell (S) | −9,000 | -$393.0K | EDGAR |
| 2011-09-14 | Sarepta Therapeutics, Inc. (AVII) Delisted | Buy (P) | +20,000 | $24.0K | EDGAR |
| 2011-06-22 | Sarepta Therapeutics, Inc. (AVII) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2011-05-26 | WES | Mixed | +3,343 | $118.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.